A stem cell treatment company claimed their stem cell therapies could reverse aging and treat, cure or prevent conditions ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

The Joint Clinical Research Centre (JCRC) at Lubowa in partnership with Asea BioTherapeutics (ABT) today successful treated their first client with cutting-edge stem cell therapy, marking a historic ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

Stem cell technology is revolutionizing cosmetic procedures. These facelifts utilize adipose-derived stem cells, extracted ...

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...